k8¿­·¢(Öйú)

ÕâÊÇÃèÊöÐÅÏ¢

ÍâÃÚÌåÑо¿

È«²¿·ÖÀà
ÁôÑÔ×Éѯ
Óë×îÐÂÏûÏ¢±£´æͬ²½
1/1
ä¯ÀÀÁ¿:
1000

ÍâÃÚÌåÑо¿·þÎñ½éÉÜ

k8¿­·¢(Öйú)×Ô2017 Äêʼ£¬È«Á¦´òÔìÍâÃÚÌ塰һվʽ¡±Ñо¿·þÎñƽ̨£¬Öð²½½¨Á¢ÁË°üº¬ÍâÃÚÌåµÄÌáÈ¡¼°¼ø¶¨¡¢ÍâÃÚÌå±ê¼Ç/ ʾ×Ù¡¢ÍâÃÚÌåµ°°×ÖÊ×éѧ/ת¼×éѧ·ÖÎöµÈÈ«·½Î»¼¼ÊõÌåϵ£¬ÒÔ¡°¸ßÆ·ÖÊ·þÎñ¡±Îª×ÚÖ¼£¬Á¦ÇóΪ¹ã´ó¿ÆÑÐÓû§ÌṩÔÚÍâÃÚÌåÑо¿·½ÃæÈ«·½Î»µÄÖ§³ÖºÍ±ãÀû¡£
ÁãÊÛ¼Û
0.0
Ôª
Êг¡¼Û
0.0
Ôª
ä¯ÀÀÁ¿:
1000
²úÆ·±àºÅ
ÊýÁ¿
-
+
¿â´æ:
0
Á¢¼´×Éѯ
1
²úÆ·ÃèÊö

       ÍâÃÚÌ壨exosomes£©ÊÇÒ»ÖÖÄܱ»»úÌåÄÚ´ó¶àÊýϸ°û·ÖÃÚµÄÖ±¾¶´óԼΪ 30 ~ 150 nm µÄ¾ßÓÐÖ¬ÖÊË«·Ö×Ó²ãĤ½á¹¹µÄ΢СÄÒÅÝ¡£´ó¶àÊýÀàÐ͵Äϸ°û¶¼¿ÉÒÔ·ÖÃÚÍâÃÚÌ壬ͬʱÍâÃÚÌåÒ²¹ã·º´æÔÚÓÚÌåÒºÖУ¬°üÀ¨ÑªÒº¡¢ÑÛÀá¡¢ÄòÒº¡¢ÍÙÒº¡¢ÈéÖ­¡¢¸¹Ë®µÈ¡£Ä¿Ç°Ñо¿·¢ÏÖÍâÃÚÌåÖи»º¬ºËËᣨmRNA¡¢microRNA¡¢lncRNA¡¢circRNA µÈ£©¡¢µ°°×¡¢Ö¬ÖʵȻîÐÔÉúÎï·Ö×Ó¡£ÍâÃÚÌåƵ·±´©ËóÓÚϸ°ûÖ®¼ä£¬ÎªÏ¸°ûÖ®¼äµÄͨÐÅÌṩÁËÇÅÁº¡£Òò´Ë£¬ÍâÃÚÌ弸ºõ¿ÉÒÔÓëÈκμ²²¡Ïà¹ØÁª£¬³ÉΪ¼²²¡±êÖ¾Îï¡¢¼²²¡»úÀí¡¢Ò©Î↑·¢µÈÑо¿µÄ´´ÐÂÈȵã¡£

 
 
 
     

|   k8¿­·¢(Öйú)ÍâÃÚÌå·þÎñÌåϵ     

       ÍâÃÚÌåµÄÑо¿ÊÇÒ»Ïîϵͳ¹¤³Ì£¬´ÓÉúÎïÑù±¾µÄ±£´æ¿ªÊ¼£¬µ½ÍâÃÚÌåµÄÌáÈ¡¡¢¼ø¶¨ÓëÖʼì¡¢ÄÚÈÝÎï×éѧ·ÖÎö¡¢ÑéÖ¤¡¢¹¦ÄÜʵÑéµÈ£¬¾ùÐè½Ï¸ß¼¼ÊõË®×¼×÷Ϊ±£ÕϲÅÄܹ»È·±£ÊµÑé½á¹ûµÄÓÅÖÊ¿É¿¿¡£k8¿­·¢(Öйú)×Ô2017 Äêʼ£¬È«Á¦´òÔìÍâÃÚÌå“һվʽ”Ñо¿·þÎñƽ̨£¬Öð²½½¨Á¢ÁË°üº¬ÍâÃÚÌåµÄÌáÈ¡¼°¼ø¶¨¡¢ÍâÃÚÌå±ê¼Ç/ ʾ×Ù¡¢ÍâÃÚÌåµ°°×ÖÊ×éѧ/ת¼×éѧ·ÖÎöµÈÈ«·½Î»¼¼ÊõÌåϵ£¬ÒÔ“¸ßÆ·ÖÊ·þÎñ”Ϊ×ÚÖ¼£¬Á¦ÇóΪ¹ã´ó¿ÆÑÐÓû§ÌṩÔÚÍâÃÚÌåÑо¿·½ÃæÈ«·½Î»µÄÖ§³ÖºÍ±ãÀû¡£

|   k8¿­·¢(Öйú)ÍâÃÚÌå·þÎñÓÅÊÆ

      k8¿­·¢(Öйú)¸ù¾Ý²»Í¬µÄÑùÆ·ÀàÐͺÍÑо¿Ä¿µÄ£¬ÍƳöÓÅÑ¡µÄÍâÃÚÌå·ÖÀë·½·¨£¬²¢ÌṩȫÌ×µÄÍâÃÚÌåÑо¿¼¼Êõ·þÎñ¡£ÔÚ·ÖÀë¸ßÖÊÁ¿ÍâÃÚÌåµÄ»ù´¡ÉÏ£¬½øÐÐÍâÃÚÌåÖеĵ°°×ÖʺͺËËá×é·ÖµÄ¸ßͨÁ¿É¸Ñ¡ºÍ·ÖÎö¡£k8¿­·¢(Öйú)¿ª·¢µÄ×éѧÑо¿¼¼Êõ·þÎñÌåϵ½øÐÐÁËϵͳÐÔ´´ÐÂÓÅ»¯£¬½«Ñù±¾ÓÃÁ¿½µµÍµÄͬʱ»ñÈ¡¸ßÖÊÁ¿Êý¾Ý¡£k8¿­·¢(Öйú)ÀûÓÃ1mLѪ½¬¼´¿É½øÐÐÍâÃÚÌåµÄ·ÖÀëºÍ²âÐò£¬²¢ÄÜÎȶ¨»ñµÃ³¬¹ý1ÍòÌõ³¤Á´RNA¡£Í¬Ê±£¬k8¿­·¢(Öйú)ÀûÓÃ0.5mLѪ½¬¼´¿ÉÍê³ÉÍâÃÚÌåµÄ·ÖÀëÓëµ°°×ÖÊ×éɸѡ¹¤×÷£¬²¢²»¶Ï³å»÷ÍâÃÚÌåµ°°×ÖÊ×éѧ¼ì²âµÄÉÏÏÞ£¬ÀýÈ磺ÔÚÈËÍâÃÚÌåѪ½¬µ°°××é¼ø¶¨ÀúÊ·¼Ç¼ÒÑ´ïµ½2336ÖÖµ°°×ÖÊ£¬²¢ÇÒÕâ¸öÊý¾Ý¼Ç¼ÿÌ춼¿ÉÄܱ»ÔÙ´ÎÍ»ÆÆ¡£

 

|   k8¿­·¢(Öйú)ÍâÃÚÌåÏîÄ¿¾­Ñé

       ½ØֹĿǰ£¬k8¿­·¢(Öйú)ÒѾ­Íê³É³¬¹ý30ÖÖÑùÆ·ÀàÐ͵ÄÑùÆ·ÍâÃÚÌåÖƱ¸Óë·ÖÎö¡£¶ÔÓÚÌØÊâÑù±¾È磺θҺ¡¢ÄÔ»ýÒº¡¢ÄÔ¼¹Òº¡¢µ¨Ö­¡¢Î¢ÉúÎïÅàÑøÒº¡¢Ö²ÎïÅàÑøÒºµÈ£¬Ò²ÀÛ»ýÁ˷ḻµÄÏîÄ¿¾­Ñ飬¿É³Ð½Ó¸´ÔÓÑùÆ·ºÍÏîÄ¿µÄÑо¿·þÎñÐèÇó¡£

|   ¿Í»§ÎÄÏ×

[1].Chen R, Feng T, Cheng S et al. Evaluating the defect targeting effects and osteogenesis promoting capacity of exosomes from 2D-and 3D-cultured human adipose-derived stem cells. Nano Today, 2023, 49: 101789.£¨ÖйúÈËÃñ½â·Å¾ü×ÜÒ½Ôº£©IF=17.4

[2].Du X, Jiang Y, Zhang Q et al. Genome-Wide Profiling of Exosomal Long Noncoding RNAs Following Air Pollution Exposure: A Randomized, Crossover Trial. Environ Sci Technol. 2023 Feb 21;57(7):2856-2863.£¨¸´µ©´óѧ¹«¹²ÎÀÉúѧԺ£©IF=11.4

[3].Zhang Luwen, Zhao Qiong, Cang Hui et al. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities. Adv Sci (Weinh), 2022, undefined: e2105811. £¨Õã½­´óѧҽѧԺ¸½Êô¶ùͯҽԺ£©IF=15.1

[4]. Luo Liwen, Gong Junfeng, Wang Zhouguang, et al. Injectable cartilage matrix hydrogel loaded with cartilage endplate stem cells engineered to release exosomes for non-invasive treatment of intervertebral disc degeneration. Bioact Mater, 2022, 15: 29-43. £¨µÚÈý¾üÒ½´óѧÐÂÇÅÒ½Ôº£©IF=18.9

[5]. Xia Chengjie, Xu Weiming, Ai Xin, et al. Autophagy and Exosome Coordinately Enhance Macrophage M1 Polarization and Recruitment in Influenza A Virus Infection. Front Immunol, 2022, 13: 722053. £¨¸´µ©´óѧҩѧԺ£©IF=7.3

[6]. Du Xihao, Zhang Qingli, Jiang Yixuan, et al. Dynamic molecular choreography induced by traffic exposure: A randomized, crossover trial using multi-omics profiling. J Hazard Mater, 2022, 424: 127359.£¨¸´µ©´óѧ¹«¹²ÎÀÉúѧԺ£©IF=13.6

[7].Xiang Z, Jiang B, Li W et al. The diagnostic and prognostic value of serum exosome-derived carbamoyl phosphate synthase 1 in HEV-related acute liver failure patients. J Med Virol. 2022 Oct;94(10):5015-5025.£¨¹ÃËÕҽѧԺ¸½ÊôËÕÖÝÒ½Ôº£©IF=12.7

[8].Du X, Zhang Q, Jiang Y et al. Characterization of plasma-derived exosomal miRNA changes following traffic-related air pollution exposure: A randomized, crossover trial based on small RNA sequencing. Environ Int. 2022 Sep;167:107430.£¨¸´µ©´óѧ¹«¹²ÎÀÉúѧԺ£©IF=11.8

[9].Qiao H, Mei J, Yuan K et al. Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles. J Nanobiotechnology. 2022 Jul 14;20(1):323.£¨ÉϺ£ÊеھÅÈËÃñÒ½Ôº£©IF=10.2

[10].Feng W, Jin Q, Ming-Yu Y et al. MiR-6924-5p-rich exosomes derived from genetically modified Scleraxis-overexpressing PDGFRα(+) BMMSCs as novel nanotherapeutics for treating osteolysis during tendon-bone healing and improving healing strength. Biomaterials. 2021 Dec;279:121242.£¨µÚÈý¾üÒ½´óѧµÚÒ»¸½ÊôÒ½Ôº£©IF=14.0

[11]. Qiao Yang, Mingjing Chen, Jiaoyang Gu, et al. Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients. Front Immunol. 2021 Apr 16;12:665133.£¨Â½¾ü¾üÒ½´óѧÐÂÇÅÒ½Ôº£©IF=7.3

[12].Zhang Z, Xu R, Yang Y et al. Micro/nano-textured hierarchical titanium topography promotes exosome biogenesis and secretion to improve osseointegration. J Nanobiotechnology. 2021 Mar 19;19(1):78.£¨ÖÐɽ´óѧ¸½Êô¿ÚǻҽԺ£©IF=10.2

[13].Chen CW, Fu M, Du ZH et al. Long Noncoding RNA MRPL23-AS1 Promotes Adenoid Cystic Carcinoma Lung Metastasis. Cancer Res. 2020 Jun 1;80(11):2273-2285.£¨±±¾©´óѧ¿ÚǻҽѧԺºÍ¿ÚǻҽԺÖÐÐÄʵÑéÊÒ£©IF=11.2

[14]. Wang T, Jian Z, Baskys A, et al. MSC-derived exosomes protect against oxidative stress-induced skin injury via adaptive regulation of the NRF2 defense system. Biomaterials, 2020, 257: 120264. £¨Î÷°²ÊÐÖÐÐÄÒ½Ôº£©IF=14.0

[15]. Ruixiang Li, Yuwei He, Ying Zhu, et al. Expressway to Rheumatoid Arthritis by Macrophage-derived Microvesicle-Coated Nanoparticles. Nano Lett. 2019 Jan 9;19(1):124-134.£¨¸´µ©´óѧÖÇÄÜ»¯µÝÒ©½ÌÓý²¿ÖصãʵÑéÊÒ£©IF=10.8

[16].Qiao L, Hu S, Liu S et al. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. J Clin Invest. 2019 Apr 29;129(6):2237-2250.£¨±±¿¨ÂÞÀ´ÄÉÖÝÁ¢´óѧ·Ö×ÓÉúÎïҽѧ¿Æѧϵ£©IF=15.9

[17]. Zhenzhen Chen, Liangshun You, Lei Wang, et al. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo. J Exp Clin Cancer Res. 2018 Aug 13;37(1):190.£¨Õã½­´óѧҽѧԺ¸½ÊôµÚÒ»Ò½Ôº£©IF=11.3

¹Ø¼ü´Ê:
ÍâÃÚÌå
ÍâÃÚÌåÑо¿
ÍâÃÚÌåÑо¿·þÎñ
ÍâÃÚÌåµ°°××é
ÍâÃÚÌåmiRNA
δÕÒµ½ÏàÓ¦²ÎÊý×飬ÇëÓÚºǫ́ÊôÐÔÄ£°åÖÐÌí¼Ó
ÉÏÒ»¸ö
k8¿­·¢(Öйú)

µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã

µç»°£º400-869-2936£¬021-33968791

ÓÊÏ䣺support@wayenbiotech.com

´«Õ棺021-33938792

QQ£º2120485725

Õ½ÂÔºÏ×÷

Õ½ÂÔºÏ×÷

·¢²¼Ê±¼ä£º2021-08-11 17:21:10

|    Full Moon    |    RayBiotech    |    CDI    |    IZON    |    Bio-Rad    |    R&D Systems    |    IsoPlexis    |    ÄÏÄ£ÉúÎï    |    Å·Ò×ÉúÎï    |    ÆäÃ÷ÐÅÏ¢    |    ÃÀ¼ªÉúÎï    |    ÂóÌØ»æÆ×    | 

 

Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿­·¢(Öйú)Ô­´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿­·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£

רÀû´úÂë

·¢²¼Ê±¼ä£º2023-06-09 17:38:30
Copyright @ 2021 ÉϺ£k8¿­·¢(Öйú)Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ °æȨËùÓÐ
Record »¦ICP±¸2022031428ºÅ-1
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ÉϺ£
ËÑË÷
ËÑË÷
¹Ø±Õ
¿Í»§ÁôÑÔ
ÑéÖ¤Âë